Reduction of withdrawal signs after chronic nicotine exposure of alpha-calcitonin gene-related peptide knock-out mice

[1]  J. Changeux,et al.  The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. , 2002, Journal of neurobiology.

[2]  D. Malin.  Nicotine dependence: studies with a laboratory model. , 2001, Pharmacology, biochemistry, and behavior.

[3]  J. Changeux,et al.  Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in αCGRP-deficient mice , 2001, Nature Neuroscience.

[4]  G F Koob,et al.  Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. , 2000, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[5]  C. Stockmeier,et al.  Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. , 1999, The Journal of pharmacology and experimental therapeutics.

[6]  L. Khiroug,et al.  Calcitonin Gene-Related Peptide Rapidly Downregulates Nicotinic Receptor Function and Slowly Raises Intracellular Ca2+ in Rat Chromaffin Cells In Vitro , 1999, The Journal of Neuroscience.

[7]  J. Changeux,et al.  Modulation of morphine analgesia in αcgrp mutant mice , 1999 .

[8]  E. Domino.  Tobacco Smoking and Nicotine Neuropsychopharmacology: Some Future Research Directions , 1998, Neuropsychopharmacology.

[9]  A. Nordberg,et al.  Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  J. Changeux,et al.  Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.

[11]  M. Zarrindast,et al.  Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice. , 1996, European journal of pharmacology.

[12]  J. Lake,et al.  The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat , 1994, Psychopharmacology.

[13]  J. Lake,et al.  Naloxone precipitates nicotine abstinence syndrome in the rat , 1993, Psychopharmacology.

[14]  I. Laakso,et al.  Plasma nicotine and cotinine concentrations in mice after chronic oral nicotine administration and challenge doses , 1993 .

[15]  T. Hökfelt,et al.  CGRP-like immunoreactivity in A11 dopamine neurons projecting to the spinal cord and a note on CGRP-CCK cross-reactivity , 1993, Brain Research.

[16]  T. Hökfelt,et al.  Calcitonin Gene‐Related Peptide in the Brain, Spinal Cord, and Some Peripheral Systems a , 1992, Annals of the New York Academy of Sciences.

[17]  J. Changeux,et al.  Calcitonin gene-related peptide enhances the rate of desensitization of the nicotinic acetylcholine receptor in cultured mouse muscle cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Jarvik,et al.  Acute and chronic tolerance to nicotine measured by activity in rats , 1973, Psychopharmacologia.

[19]  W. Corrigall,et al.  Nicotine maintains robust self-administration in rats on a limited-access schedule , 2004, Psychopharmacology.

[20]  P. Clarke,et al.  Effects of Nicotine on Biological Systems II , 1995, Advances in Pharmacological Sciences.

[21]  I. Stolerman,et al.  The neurobiology of tobacco addiction. , 1991, Trends in pharmacological sciences.

[22]  P. Clarke.  The Mesolimbic Dopamine System as a Target for Nicotine , 1991 .